We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome in Patients With Brain Tumors (DM-CHOC-PEN)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT02038218
First Posted: January 16, 2014
Last Update Posted: June 23, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Tulane University Medical Center, New Orleans, LA
Icahn School of Medicine at Mount Sinai
Detroit Clinical Research Center, Farmington Hills, Lansing and Owasso, MI
National Cancer Institute (NCI)
Ochsner Health System
The University of Texas Health Science Center, Houston
Information provided by (Responsible Party):
DEKK-TEC, Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2016
  Primary Completion Date: May 2016 (Final data collection date for primary outcome measure)